SNN
SMITH & NEPHEW PLCMarquee-fund ownership over time
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Bridgewater Associates | Q3 2021 | 20Q | $34 | $30 | -10% |
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $28 | $30 | +7% |
| D.E. Shaw | Q4 2024(8Q snapshot) | 6Q | $24 | $30 | +28% |
| Millennium Management | Q1 2025(8Q snapshot) | 5Q | $25 | $30 | +23% |
| AQR Capital Management | Q3 2025(8Q snapshot) | 3Q | $36 | $30 | -15% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies | Q3 2025 | Q4 2025 | → $32 | -10% |
| Point72 Asset Management | Q1 2025 | Q2 2025 | → $28 | +14% |
| Maverick Capital | Q4 2024 | Q1 2025 | → $25 | +4% |
Fundamentals
XBRL · SMITH & NEPHEW PLCNot enough XBRL history to plot. SMITH & NEPHEW PLChasn't tagged revenue, net income, EPS, or operating cash flow in the SEC us-gaap taxonomy with at least two fiscal-year periods — typical for SPACs / trust vehicles, pre-revenue biotechs, recent IPOs, and foreign filers reporting under IFRS.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for SMITH & NEPHEW PLC — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 6-KDIRECTOR/PDMR SHAREHOLDINGJun 4, 2026
- 6-KDIRECTOR/PDMR SHAREHOLDINGJun 3, 2026
- 6-KADMISSION TO TRADINGJun 3, 2026
- 6-KTOTAL VOTING RIGHTSJun 1, 2026
- 6-KADMISSION TO TRADINGMay 22, 2026
- 6-KDIRECTOR/PDMR SHAREHOLDINGMay 20, 2026
- 6-KHOLDING(S) IN COMPANYMay 19, 2026
- 6-KHOLDING(S) IN COMPANYMay 14, 2026
- 6-KSTERLING AMOUNT OF DIVIDENDMay 12, 2026
- 6-KSHARE BUYBACK PROGRAMMEMay 8, 2026
- 6-KRESULT OF AGMMay 6, 2026
- 6-KSMITH+NEPHEW FIRST QUARTER 2026 TRADING UPDATEMay 6, 2026
- 6-KInterim disclosure (foreign)May 6, 2026
- 6-KTOTAL VOTING RIGHTSMay 1, 2026
- 6-KEXPERT SURGEONS INSIGHTS EVENT FOR INVESTORSApr 27, 2026
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| AQR Capital Management | Q3 2025 | open | $36 | $30 | -15% |
| Renaissance Technologies | Q3 2025 | Q4 2025 | $36 | $32 | -10% |
| Millennium Management | Q1 2025 | open | $25 | $30 | +23% |
| Point72 Asset Management | Q1 2025 | Q2 2025 | $25 | $28 | +14% |
| D.E. Shaw | Q4 2024 | open | $24 | $30 | +28% |
| Maverick Capital | Q4 2024 | Q1 2025 | $24 | $25 | +4% |
| Citadel Advisors | Q3 2024 | open | $28 | $30 | +7% |
| Bridgewater Associates | Q3 2021 | open | $34 | $29 | -13% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.